-65.7%
MRNA vs PSA
+13.7%
-79.4%
-95.1%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | PSA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +0.6% | +4.7% | +5.0% |
| 7D | -1.1% | -1.8% | +0.7% | 0.0% |
| 30D | +126.1% | -8.4% | +134.5% | +138.0% |
| 3M | +190.0% | -7.8% | +197.9% | +202.5% |
| 6M | +157.2% | +0.8% | +156.4% | +154.7% |
| YTD | +388.2% | +16.5% | +371.7% | +348.0% |
| 1Y | +467.0% | +4.7% | +462.3% | +448.5% |
| 3Y | +36.1% | +21.1% | +15.0% | +20.6% |
| All | -65.7% | +13.7% | -79.4% | -70.3% |
Cumulative growth
Daily Returns
Daily percentage return beside PSA.
Daily Out/Under-Performance
Portfolio return minus PSA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PSA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded PSA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling